Pages that link to "Q34756676"
Jump to navigation
Jump to search
The following pages link to Protein-protein interactions as druggable targets: recent technological advances (Q34756676):
Displaying 50 items.
- Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics (Q26775356) (← links)
- Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction Networks (Q26784027) (← links)
- Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders (Q33606810) (← links)
- Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain (Q34066239) (← links)
- The re-emergence of natural products for drug discovery in the genomics era. (Q34459318) (← links)
- Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions (Q34481459) (← links)
- Prediction and redesign of protein-protein interactions (Q34580039) (← links)
- 2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine. (Q35033136) (← links)
- Structure-based design of small-molecule protein-protein interaction modulators: the story so far. (Q35103944) (← links)
- Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space (Q35158672) (← links)
- Selective Targeting of the TPX2 Site of Importin-α Using Fragment-Based Ligand Design (Q35610949) (← links)
- Alternative modulation of protein-protein interactions by small molecules (Q35620999) (← links)
- State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors (Q35738960) (← links)
- Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide. (Q35822572) (← links)
- Protein-protein interactions as drug targets (Q35824701) (← links)
- Biophysics in drug discovery: impact, challenges and opportunities. (Q36102317) (← links)
- Screening-based approaches to identify small molecules that inhibit protein-protein interactions (Q36244148) (← links)
- Targeting the WASF3-CYFIP1 Complex Using Stapled Peptides Suppresses Cancer Cell Invasion (Q36790763) (← links)
- Local cAMP signaling in disease at a glance (Q37226387) (← links)
- New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins. (Q37679748) (← links)
- Protein-protein interaction networks studies and importance of 3D structure knowledge (Q38160928) (← links)
- Many players in BCL-2 family affairs (Q38185804) (← links)
- Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities (Q38252591) (← links)
- From workstations to workbenches: Towards predicting physicochemically viable protein-protein interactions across a host and a pathogen (Q38289852) (← links)
- Modulating protein-protein interactions: the potential of peptides (Q38314370) (← links)
- Structure of human dipeptidyl peptidase 10 (DPPY): a modulator of neuronal Kv4 channels. (Q38445059) (← links)
- Identifying functionally important cis-peptide containing segments in proteins and their utility in molecular function annotation. (Q38471793) (← links)
- K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target? (Q38731776) (← links)
- Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors (Q38732067) (← links)
- Glial cells as drug targets: What does it take? (Q38819291) (← links)
- New prospects for targeting telomerase beyond the telomere. (Q38875386) (← links)
- Personalized and targeted therapy of esophageal squamous cell carcinoma: an update (Q38892190) (← links)
- Narrowing the translational research gap: what needs to be done? (Q38961461) (← links)
- Intrinsic protein disorder in oncogenic KRAS signaling (Q39361391) (← links)
- Predicting Protein-Protein Interactions Using BiGGER: Case Studies. (Q39495816) (← links)
- Developing a PPI inhibitor-based therapy for STXBP1 haploinsufficiency-associated epileptic disorders (Q41910332) (← links)
- Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology (Q42701435) (← links)
- Efflux by small multidrug resistance proteins is inhibited by membrane-interactive helix-stapled peptides (Q42729942) (← links)
- Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein. (Q47152351) (← links)
- Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action (Q47287433) (← links)
- Molecular engineering solutions for therapeutic peptide delivery. (Q47680427) (← links)
- Targeting the Genome-Stability Hub Ctf4 by Stapled-Peptide Design (Q47942361) (← links)
- A precisely positioned chiral center in an i, i 7 tether modulates the helicity of the backbone peptide. (Q48774684) (← links)
- Astrocytes and the Warning Signs of Intracerebral Hemorrhagic Stroke. (Q52659360) (← links)
- Constructing thioether-tethered cyclic peptides via on-resin intra-molecular thiol-ene reaction. (Q53862367) (← links)
- Targeted Intracellular Delivery of Antibodies: The State of the Art (Q58566968) (← links)
- Protein-protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics (Q59813277) (← links)
- Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. (Q64892301) (← links)
- Drug discovery: tools and rules for macrocycles (Q87413192) (← links)
- Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development (Q90049859) (← links)